AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. PYXS
  4. [SCHEDULE 13G/A] Pyxis Oncology, Inc. SEC Filing

[SCHEDULE 13G/A] Pyxis Oncology, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source:

Stock PYXS logo
Pyxis Oncology, Inc.

NASDAQ:PYXS

PYXS Rankings

#4946 Ranked by Market Cap
N/A Ranked by Dividends
#65 Top Gainer

PYXS Latest News

Aug 21, 2025
Pyxis Oncology to Participate in September Investor and Industry Conferences
Aug 14, 2025
Pyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update
Jun 30, 2025
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 15, 2025
Pyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business Update
May 14, 2025
Pyxis Oncology to Participate in Two Upcoming Investor Conferences

PYXS Latest SEC Filings

Aug 14, 2025
[10-Q] Pyxis Oncology, Inc. Quarterly Earnings Report
Aug 14, 2025
[8-K] Pyxis Oncology, Inc. Reports Material Event
Aug 4, 2025
[8-K] Pyxis Oncology, Inc. Reports Material Event
Jul 1, 2025
[SCHEDULE 13G] Pyxis Oncology, Inc. SEC Filing
Jun 18, 2025
[8-K] Pyxis Oncology, Inc. Reports Material Event

PYXS Stock Data

76.90M
47.44M
23.39%
33.75%
7.58%
Biotechnology
Pharmaceutical Preparations
United States
BOSTON